Cargando...
Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
BACKGROUND: Severe exacerbations of COPD are commonly associated with hyperglycaemia, which predicts adverse outcomes. Metformin is a well-established anti-hyperglycaemic agent in diabetes mellitus, possibly augmented with anti-inflammatory effects, but its effects in COPD are unknown. We investigat...
Gardado en:
| Publicado en: | Thorax |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941151/ https://ncbi.nlm.nih.gov/pubmed/26917577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2015-208035 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|